1. Bremme K, Östlund E, Almqvist I, Heinonen K, Blombäck M. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol 1992;80:132-137. PMID:
1534880.
2. Bellart J, Gilabert R, Fontcuberta J, Carreras E, Miralles RM, Cabero L. Coagulation and fibrinolysis parameters in normal pregnancy and in gestational diabetes. Am J Perinatol 1998;15:479-486. PMID:
9788646.
3. Comeglio P, Fedi S, Liotta AA, Cellai AP, Chiarantini E, Prisco D, et al. Blood clotting activation during normal pregnancy. Thromb Res 1996;84:199-202. PMID:
8914219.
4. Virkus RA, Løkkegaard E, Lidegaard Ø, Langhoff-Roos J, Nielsen AK, Rothman KJ, et al. Risk factors for venous thromboembolism in 1.3 million pregnancies: a nationwide prospective cohort. PLoS One 2014;9:e96495. PMID:
24788753.
5. Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study. Am J Obstet Gynecol 2008;198:233.e1-233.e7. PMID:
17997389.
6. Chan LY, Tam WH, Lau TK. Venous thromboembolism in pregnant Chinese women. Obstet Gynecol 2001;98:471-475. PMID:
11530132.
7. Lindqvist P, Dahlbäck B, Marŝál K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol 1999;94:595-599. PMID:
10511366.
8. He S, Bremme K, Blombäck M. Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and/or kidney in preeclampsia. Blood Coagul Fibrinolysis 1997;8:232-238. PMID:
9199820.
9. Xiong Y, Zhou SF, Zhou R, Yang D, Xu ZF, Lou YT, et al. Alternations of maternal and cord plasma hemostasis in preeclampsia before and after delivery. Hypertens Pregnancy 2011;30:347-358. PMID:
21174589.
10. McKay DG. Hematologic evidence of disseminated intravascular coagulation in eclampsia. Obstet Gynecol Surv 1972;27:399-417. PMID:
4614142.
11. Reber G, Vissac AM, de Moerloose P, Bounameaux H, Amiral J. A new, semi-quantitative and individual ELISA for rapid measurement of plasma D-dimer in patients suspected of pulmonary embolism. Blood Coagul Fibrinolysis 1995;6:460-463. PMID:
8589214.
12. Szecsi PB, Jørgensen M, Klajnbard A, Andersen MR, Colov NP, Stender S. Haemostatic reference intervals in pregnancy. Thromb Haemost 2010;103:718-727. PMID:
20174768.
13. Francalanci I, Comeglio P, Alessandrello Liotta A, Cellai AP, Fedi S, Parretti E, et al. D-dimer plasma levels during normal pregnancy measured by specific ELISA. Int J Clin Lab Res 1997;27:65-67. PMID:
9144030.
14. Chabloz P, Reber G, Boehlen F, Hohlfeld P, de Moerloose P. TAFI antigen and D-dimer levels during normal pregnancy and at delivery. Br J Haematol 2001;115:150-152. PMID:
11722426.
15. Kline JA, Williams GW, Hernandez-Nino J. D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed. Clin Chem 2005;51:825-829. PMID:
15764641.
16. Kawaguchi S, Yamada T, Takeda M, Nishida R, Yamada T, Morikawa M, et al. Changes in D-dimer levels in pregnant women according to gestational week. Pregnancy Hypertens 2013;3:172-177. PMID:
26106030.
17. Francalanci I, Comeglio P, Liotta AA, Cellai AP, Fedi S, Parretti E, et al. D-dimer concentrations during normal pregnancy, as measured by ELISA. Thromb Res 1995;78:399-405. PMID:
7660356.
18. Pinheiro MB, Junqueira DR, Coelho FF, Freitas LG, Carvalho MG, Gomes KB, et al. D-dimer in preeclampsia: systematic review and meta-analysis. Clin Chim Acta 2012;414:166-170. PMID:
22922438.
19. Dusse LM, Rios DR, Pinheiro MB, Cooper AJ, Lwaleed BA. Pre-eclampsia: relationship between coagulation, fibrinolysis and inflammation. Clin Chim Acta 2011;412:17-21. PMID:
20888809.
20. American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol 2013;122:1122-1131. PMID:
24150027.
21. Giavarina D, Mezzena G, Dorizzi RM, Soffiati G. Reference interval of D-dimer in pregnant women. Clin Biochem 2001;34:331-333. PMID:
11440735.
22. Morse M. Establishing a normal range for D-dimer levels through pregnancy to aid in the diagnosis of pulmonary embolism and deep vein thrombosis. J Thromb Haemost 2004;2:1202-1204. PMID:
15219216.
23. Gaffney PJ, Creighton LJ, Callus M, Thorpe R. Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). II. Evaluation in a variety of clinical conditions. Br J Haematol 1988;68:91-96. PMID:
3345298.
24. Connaghan DG, Francis CW, Lane DA, Marder VJ. Specific identification of fibrin polymers, fibrinogen degradation products, and crosslinked fibrin degradation products in plasma and serum with a new sensitive technique. Blood 1985;65:589-597. PMID:
3971042.
25. Francis CW, Markham RE Jr, Marder VJ. Demonstration of in situ fibrin degradation in pathologic thrombi. Blood 1984;63:1216-1224. PMID:
6231967.
26. Lee AJ, Fowkes GR, Lowe GD, Rumley A. Determinants of fibrin D-dimer in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1995;15:1094-1097. PMID:
7627701.
27. Brown MA. The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol 1995;22:781-791. PMID:
8593732.
28. Cushman M, Folsom AR, Wang L, Aleksic N, Rosamond WD, Tracy RP, et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 2003;101:1243-1248. PMID:
12393393.
29. Fan J, Li X, Cheng Y, Yao C, Zhong N. Investigators Group. Measurement of D-dimer as aid in risk evaluation of VTE in elderly patients hospitalized for acute illness: a prospective, multicenter study in China. Clin Invest Med 2011;34:E96-E104. PMID:
21463550.